SpringWorks Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $59,733 | $21,006 | $5,447 | $5,586 |
Gross Profit | 56,436 | 19,075 | 4,487 | 4,653 |
EBITDA | -44,077 | -93,202 | -97,925 | -83,505 |
EBIT | -44,921 | -93,931 | -98,463 | -84,438 |
Net Income | -39,919 | -87,385 | -94,322 | -79,437 |
Net Change In Cash | 59,733 | 21,006 | 5,447 | 5,586 |
Free Cash Flow | -54,015 | -79,507 | -60,403 | -54,083 |
Cash | 79,898 | 118,031 | 176,053 | 98,895 |
Basic Shares | 74,121 | 73,768 | 73,486 | 62,521 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $5,447 | $6,147 | $35,000 | $35,000 |
Gross Profit | 5,025 | 6,147 | -490 | 34,651 |
EBITDA | -341,346 | -279,909 | -172,978 | -45,975 |
EBIT | -343,013 | -280,674 | -173,468 | -46,324 |
Net Income | -325,104 | -274,160 | -173,212 | -44,244 |
Net Change In Cash | 5,447 | 6,147 | 35,000 | 35,000 |
Free Cash Flow | -230,180 | -171,759 | -129,893 | -32,833 |
Cash | 176,053 | 67,490 | 103,961 | 147,089 |
Basic Shares | 63,123 | 53,290 | 48,497 | 43,300 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.54 |
2024-03-31 | -$1.18 |
2023-12-31 | -$1.45 |
2023-09-30 | -$1.27 |
